Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsReceivables - NetReceivables - OtherShares Repurchased
Ratios

Corcept Therapeutics (CORT) Shares Repurchased (2018 - 2025)

Corcept Therapeutics (CORT) has disclosed Shares Repurchased for 6 consecutive years, with $42.5 million as the latest value for Q3 2025.

  • Quarterly Shares Repurchased rose 263.25% to $42.5 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $172.9 million through Dec 2025, up 1003.17% year-over-year, with the annual reading at $172.9 million for FY2025, 1003.9% up from the prior year.
  • Shares Repurchased hit $42.5 million in Q3 2025 for Corcept Therapeutics, down from $103.0 million in the prior quarter.
  • In the past five years, Shares Repurchased ranged from a high of $119.0 million in Q4 2021 to a low of $476000.0 in Q1 2024.
  • Historically, Shares Repurchased has averaged $39.6 million across 3 years, with a median of $28.3 million in 2021.
  • Biggest five-year swings in Shares Repurchased: soared 43378.18% in 2021 and later skyrocketed 263.25% in 2025.
  • Year by year, Shares Repurchased stood at $119.0 million in 2021, then plummeted by 90.17% to $11.7 million in 2024, then surged by 263.25% to $42.5 million in 2025.
  • Business Quant data shows Shares Repurchased for CORT at $42.5 million in Q3 2025, $103.0 million in Q2 2025, and $27.4 million in Q1 2025.